FR2515039A1 - Sels de l'acide sulfodehydroabietique et leur utilisation pour le traitement de maladies gastro-intestinales - Google Patents

Sels de l'acide sulfodehydroabietique et leur utilisation pour le traitement de maladies gastro-intestinales Download PDF

Info

Publication number
FR2515039A1
FR2515039A1 FR8217722A FR8217722A FR2515039A1 FR 2515039 A1 FR2515039 A1 FR 2515039A1 FR 8217722 A FR8217722 A FR 8217722A FR 8217722 A FR8217722 A FR 8217722A FR 2515039 A1 FR2515039 A1 FR 2515039A1
Authority
FR
France
Prior art keywords
salt
amine
acid
alkyl
amino
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
FR8217722A
Other languages
English (en)
French (fr)
Other versions
FR2515039B1 (en:Method
Inventor
Hiroshi Wada
Masatoshi Kawamori
Hajime Tamaki
Yuchi Onoda
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Mitsubishi Tanabe Pharma Corp
Original Assignee
Tanabe Seiyaku Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB08131856A external-priority patent/GB2107584A/en
Application filed by Tanabe Seiyaku Co Ltd filed Critical Tanabe Seiyaku Co Ltd
Publication of FR2515039A1 publication Critical patent/FR2515039A1/fr
Application granted granted Critical
Publication of FR2515039B1 publication Critical patent/FR2515039B1/fr
Granted legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C309/00Sulfonic acids; Halides, esters, or anhydrides thereof
    • C07C309/01Sulfonic acids
    • C07C309/28Sulfonic acids having sulfo groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton
    • C07C309/57Sulfonic acids having sulfo groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton containing carboxyl groups bound to the carbon skeleton
    • C07C309/58Carboxylic acid groups or esters thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2603/00Systems containing at least three condensed rings
    • C07C2603/02Ortho- or ortho- and peri-condensed systems
    • C07C2603/04Ortho- or ortho- and peri-condensed systems containing three rings
    • C07C2603/22Ortho- or ortho- and peri-condensed systems containing three rings containing only six-membered rings
    • C07C2603/26Phenanthrenes; Hydrogenated phenanthrenes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pyrrole Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
FR8217722A 1981-10-22 1982-10-22 Sels de l'acide sulfodehydroabietique et leur utilisation pour le traitement de maladies gastro-intestinales Granted FR2515039A1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB08131856A GB2107584A (en) 1981-10-22 1981-10-22 Treatment of gastro-intestinal diseases
GB8218707 1982-06-29

Publications (2)

Publication Number Publication Date
FR2515039A1 true FR2515039A1 (fr) 1983-04-29
FR2515039B1 FR2515039B1 (en:Method) 1985-03-22

Family

ID=26281038

Family Applications (1)

Application Number Title Priority Date Filing Date
FR8217722A Granted FR2515039A1 (fr) 1981-10-22 1982-10-22 Sels de l'acide sulfodehydroabietique et leur utilisation pour le traitement de maladies gastro-intestinales

Country Status (10)

Country Link
US (1) US4529602A (en:Method)
EP (1) EP0078152B1 (en:Method)
JP (1) JPH02167258A (en:Method)
DE (2) DE3271037D1 (en:Method)
DK (1) DK172690B1 (en:Method)
FR (1) FR2515039A1 (en:Method)
GB (1) GB2114975B (en:Method)
HK (1) HK41588A (en:Method)
IT (1) IT1196554B (en:Method)
SG (1) SG10788G (en:Method)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4882271A (en) * 1988-03-10 1989-11-21 Baylor College Of Medicine Process for preparation of high molecular weight cell-associated protein of campylobacter pylori and use for serological detection of campylobacter pylori infection
USRE34101E (en) * 1991-03-19 1992-10-13 Baylor College Of Medicine Process for preparation of high molecular weight cell-associated protein of Campylobacter pylori and use for serological detection of Campylobacter pylori infection
IT1262896B (it) * 1992-03-06 1996-07-22 Composti coniugati formati da proteine heat shock (hsp) e oligo-poli- saccaridi, loro uso per la produzione di vaccini.
US5336503A (en) * 1992-03-31 1994-08-09 Daiichi Pharmaceutical Co., Ltd. Anti-peptic ulcer agent
JP3059092B2 (ja) * 1995-11-15 2000-07-04 田辺製薬株式会社 ドライアイおよびドライアイを原因とする疾患の予防・治療剤
TW585762B (en) * 1999-11-11 2004-05-01 Tanabe Seiyaku Co Pharmaceutical composition for prophylaxis or treatment of inflammatory bowel diseases
US20030099703A1 (en) * 2000-08-11 2003-05-29 Shigeru Aoki Drug-containing solid dispersion having improved solubility
FI20010233A0 (fi) * 2001-02-08 2001-02-08 Orion Corp Menetelmä sydämen vajaatoiminnan hoitoon
US7752419B1 (en) 2001-03-22 2010-07-06 Qst Holdings, Llc Method and system for managing hardware resources to implement system functions using an adaptive computing architecture
US7249242B2 (en) 2002-10-28 2007-07-24 Nvidia Corporation Input pipeline registers for a node in an adaptive computing engine
US7400668B2 (en) 2001-03-22 2008-07-15 Qst Holdings, Llc Method and system for implementing a system acquisition function for use with a communication device
US7489779B2 (en) 2001-03-22 2009-02-10 Qstholdings, Llc Hardware implementation of the secure hash standard
CA2443944A1 (en) * 2001-04-17 2002-10-31 Tanabe Seiyaku Co., Ltd. Agent for prophylaxis or treatment of inflammatory diseases in mucosa of oral cavity and the like
CN1219757C (zh) * 2001-07-16 2005-09-21 中国医药研究开发中心有限公司 磺化去氢松香酸盐及其制备方法和其用途
US20040259905A1 (en) * 2001-09-27 2004-12-23 Shinji Narisawa Aqueous ecabet sodium solution preparation
US7046635B2 (en) 2001-11-28 2006-05-16 Quicksilver Technology, Inc. System for authorizing functionality in adaptable hardware devices
US7602740B2 (en) 2001-12-10 2009-10-13 Qst Holdings, Inc. System for adapting device standards after manufacture
US7215701B2 (en) 2001-12-12 2007-05-08 Sharad Sambhwani Low I/O bandwidth method and system for implementing detection and identification of scrambling codes
US7493375B2 (en) 2002-04-29 2009-02-17 Qst Holding, Llc Storage and delivery of device features
US7478031B2 (en) 2002-11-07 2009-01-13 Qst Holdings, Llc Method, system and program for developing and scheduling adaptive integrated circuity and corresponding control or configuration information
US7609297B2 (en) 2003-06-25 2009-10-27 Qst Holdings, Inc. Configurable hardware based digital imaging apparatus
CN101590031B (zh) * 2008-06-17 2011-10-12 浙江爱生药业有限公司 磺化去氢松香酸二钠组合物的制备方法
FI124101B (en) 2012-05-14 2014-03-14 Hankkija Maatalous Oy Modified tall oil fatty acid
FI124918B (fi) 2013-05-14 2015-03-31 Hankkija Maatalous Oy Mäntyöljyrasvahappo
FI125051B (fi) 2013-10-24 2015-05-15 Hankkija Oy Mäntyöljyrasvahappo
MX385015B (es) 2013-11-13 2025-03-14 Hankkija Oy Suplemento alimenticio.
CN103772241B (zh) * 2014-01-07 2015-08-26 珠海亿邦制药股份有限公司 一种磺化去氢松香酸盐的制备方法
CN104447432B (zh) * 2014-11-21 2018-01-26 珠海亿邦制药股份有限公司 一种新的磺化去氢松香酸铋的制备方法
US10445096B2 (en) 2017-04-05 2019-10-15 Cavium, Llc Managing lock and unlock operations using traffic prioritization
WO2019089498A1 (en) * 2017-10-30 2019-05-09 Theracaine Llc Hydrophobic ammonium and phosphonium salts

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2121032A (en) * 1936-03-24 1938-06-21 G & A Lab Detergent and wetting agent and process of producing the same
FR2481270A1 (fr) * 1980-04-24 1981-10-30 Roussel Uclaf Nouveaux derives substitues de l'acide 4-phenyl 4-oxo 2-hydroxy butanoique, procede pour leur preparation et applications comme medicaments

Also Published As

Publication number Publication date
GB2114975B (en) 1985-06-05
IT8249332A0 (it) 1982-10-21
FR2515039B1 (en:Method) 1985-03-22
HK41588A (en) 1988-06-10
DK172690B1 (da) 1999-05-31
JPH0451546B2 (en:Method) 1992-08-19
DK467582A (da) 1983-04-23
GB2114975A (en) 1983-09-01
EP0078152B1 (en) 1986-05-07
IT1196554B (it) 1988-11-16
DE3239172A1 (de) 1983-05-05
DE3271037D1 (en) 1986-06-12
SG10788G (en) 1988-07-01
JPH02167258A (ja) 1990-06-27
EP0078152A1 (en) 1983-05-04
US4529602A (en) 1985-07-16

Similar Documents

Publication Publication Date Title
FR2515039A1 (fr) Sels de l'acide sulfodehydroabietique et leur utilisation pour le traitement de maladies gastro-intestinales
RU2108322C1 (ru) Производные циклоалкилзамещенного глутарамида и фармацевтическая композиция на их основе
US4412992A (en) 2-Hydroxy-5-phenylazobenzoic acid derivatives and method of treating ulcerative colitis therewith
EP0318377B1 (fr) Nouveaux composés énantiomères dérivés d'amino-acides, leur procédé de préparation et leurs applications thérapeutiques
EP0572635B1 (fr) Composes a structure guanidique et compositions pharmaceutiques les contenant
EP0110781A1 (fr) (Amino-2 éthyl)-6 benzoxazolinones substituées, leur préparation et une composition pharmaceutique les contenant
EP0532410A1 (fr) Dérivés hétérocycliques N-substitués, comme inhibiteurs de l'angiotensive II
LU86569A1 (fr) Composes inhibiteurs de l'enzyme de conversion de l'angiotensine
SK319892A3 (en) N-phenyl-2-cyano-3-hydroxycrotonamide derivatives, method of their poduction and their using for manufacture of medicines with immunomodulating effect
EP0349432B1 (fr) Sel de strontium, son procédé de préparation et les compositions pharmaceutiques le renfermant
FR2476071A1 (fr) Nouveaux acides 2-amino-3-(a-hydroxybenzyl)-phenylacetiques et leurs esters et amides, utiles notamment comme agents anti-inflammatoires, et compositions pharmaceutiques les contenant
JPS6323174B2 (en:Method)
EP0015214A1 (fr) Nouveaux dérivés de benzoyl-2 glycylanilides substitués, leur préparation et leur application en tant que médicaments anxiolytiques
CA1250838A (fr) Procede de preparation de derives de 1-(acetylaminophenyl)-2-amino-propanone et les derives ainsi obtenus
CA1082716A (fr) Procede de preparation de nouveaux derives de 5- thiazole methane amine
SU820658A3 (ru) Способ получени производных1-фЕНилэТАНОлАМиНА или иХ СОлЕй
CZ695188A3 (en) ENOL ETHER OF 1,1-DIOXIDE OF 6-CHLORO-4-HYDROXY-2-METHYL-N- (2-PYRIDYL-2H-THIENO(2,3-c)-1,2-THIAZINECARBOXYLIC ACID AMIDE, PROCESS OF ITS PREPARATION AND ITS USE
JP2000191528A (ja) ビタミンe誘導体を含有してなる抗炎症剤または抗アレルギ―剤
EP1007522B1 (fr) 2- 4-[4-(4,5-dichloro-2-methylimidazol-1-yl)butyl]piperazin-1-yl -5-fluoropyrimidine, sa preparation et son utilisation therapeutique
WO2005037774A1 (en) Novel molecules to develop drug for the treatment of osteoporosis
WO2000005242A1 (en) Dehydroepiandrosterone derivatives for prophylaxis and treatment of osteoporosis
JP2007530424A (ja) 新規N−ヒドロキシ−4−(3−フェニル−5−メチル−イソオキサゾール−4−yl)−ベンゼンスルホンアミドの溶媒和物
HU203839B (en) Process for producing pharmaceutical composition containing acrylic acid derivatives
FR2478632A1 (fr) Derives mercaptoacyles de la proline et de l'acide pipecolique a fonction cetonique, a action anti-hypertensive
BE875365A (fr) Acides 4-thiazolidine-carboxyliques a activite antihypertensive

Legal Events

Date Code Title Description
ST Notification of lapse